Navigation Links
New paradigm for cell-specific gene delivery
Date:6/22/2008

Researchers from Northwestern University and Texas A & M University have discovered a new way to limit gene transfer and expression to specific tissues in animals. In studies to determine how plasmids enter the nuclei of non-dividing cells, the group previously identified a region of a smooth muscle cell-specific promoter that was able to mediate nuclear targeting of any plasmid carrying this sequence uniquely in cultured smooth muscle cells but in no other cell type. In their current study to appear in the July 08 issue of Experimental Biology and Medicine, the team, led by Drs. David Dean and Jennifer Young from the Department of Medicine at Northwestern University, in collaboration with Warren Zimmer from Texas A & M University, now demonstrate that such restriction of nuclear entry using this specific DNA sequence can be used in blood vessels of living animals to direct gene transfer and expression specifically to smooth muscle cells. They have also developed a novel gene delivery approach for the vasculature that uses an electric field to transiently permeabilize the plasma membrane of cells to allow entry of DNA. Thus, this work establishes the control of nuclear entry of gene therapy vectors as a novel approach to target genes and gene expression to desired cell types in the body.

Vascular smooth muscle proliferative diseases, including atherosclerosis and restenosis, are among the leading causes of morbidity and mortality in the US. Gene therapy may represent an important alternative for the treatment and prevention of these proliferative diseases of the vasculature. It can be highly cell-specific, mimic or restore normal in vivo function, and can be permanent or transient depending on vector design. Currently, a number of gene delivery systems for use on the arterial wall are being studied, but as yet their low efficiency in gene transfer and lack of cell-specific targeting and expression are major limitations. According to Dr. D
'/>"/>

Contact: Dr. David Dean
david_dean@urmc.rochester.edu
585-276-3933
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Lets talk -- new paradigms in the research of the biomolecular composition of water
2. Paradigm shift in Alzheimerss research: new treatments
3. Test of bacteria toxin delivery system could pave way for new antibiotic drugs
4. MIT: Stripes key to nanoparticle drug delivery
5. Micro-origami: USC folds up micrometer-scale voxels for drug delivery
6. Fewer babies born after Caesarean delivery
7. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
8. e-SMART Technologies Continues Delivery of Its New Super SMART Card in South Korea
9. Researchers develop better membranes for water treatment, drug delivery
10. Carnegie Mellon researchers to develop new drug delivery system
11. Computer solution to delivery problem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/21/2013)... attached to a whale entangled in fishing gear, scientists ... a whale,s diving and swimming behavior. The monitoring revealed ... migrate, depletes their energy as they drag gear for ... death. , The scientists in this entanglement response suction-cupped ... female North Atlantic right whale called Eg 3911. The ...
(Date:5/21/2013)... method for delivering molecules into single, targeted cells ... technique could find applications in drug delivery, cell ... a technique used to deliver molecules into ... that are caused by exposing them to electric ... cell transfection. (Cell transfection is the introduction of ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Single-cell transfection tool enables added control for biological studies 2
... and heavy smokers develop Alzheimers disease years earlier than ... heavily, according to research that will be presented at ... in Chicago, April 1219, 2008. These results are ... or eliminate heavy smoking and drinking, we could substantially ...
... The vitamin industry has long touted antioxidants as a ... diet, but a new review of studies found no ... review authors said that some antioxidants could increase risk ... the nutraceuticals industry, but an antioxidant researcher with the ...
... from the National Institute of Standards and Technology ... Ground have developed reliable methods based on DNA ... anthrax spores after prolonged storage. The techniques and ... reference standard for anthrax detection and decontamination. ...
Cached Biology News:Alzheimer's starts earlier for heavy drinkers, smokers 2Antioxidant users don't live longer, analysis of studies concludes 2Antioxidant users don't live longer, analysis of studies concludes 3NIST, Army researchers pave the way for anthrax spore standards 2
(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...
(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
(Date:5/21/2013)... Md. , May 21, 2013  MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM.  The presentation ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
... preclinical and Phase 1 safety studies, and plans for ... hyperplasia (BPH) are to be presentedCINCINNATI, May 14 ... medicines for an aging global population, will lead off ... 19, 2009 at 9:00 AM in Atlanta, Georgia. Ausio ...
... vs. prior year -DENVER, May 14 Corgenix Medical Corporation ... diagnostic test kits, today filed its third quarter Form 10-Q ... sales have increased during the quarter ended March 31, 2009, ... the results highlighted by the report are as follows:, ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) (TSX: ... million or $0.13 per basic and diluted share for the ... of $5.1 million or $0.26 per basic and diluted share ... loss is primarily the result of the transfer of manufacturing ...
Cached Biology Technology:Ausio Pharmaceuticals to Present at Bio(R) 2009 2Corgenix Reports Third Quarter Fiscal 2009 Financial Results 2Corgenix Reports Third Quarter Fiscal 2009 Financial Results 3Corgenix Reports Third Quarter Fiscal 2009 Financial Results 4Oncothyreon reports first quarter 2009 financial results 2Oncothyreon reports first quarter 2009 financial results 3Oncothyreon reports first quarter 2009 financial results 4Oncothyreon reports first quarter 2009 financial results 5